Introduction
Cardiovascular complications are frequent in patients with diabetes mellitus and confer a very poor prognosis, especially in patients whose illness is poorly controlled and of long duration. In addition to the high incidence of myocardial infarction due to epicardial coronary arteriosclerosis, coronary teriosclerotic disease (3, 4) , and may also be involved in the pathogenesis of diabetic cardiomyopathy in patients with diabetes mellitus secondary to microvascular disease (5) . Several investigators have reported that CFR and endothelial function were impaired in diabetic patients without epicardial coronary artery stenosis (1, 2, 5) . Pitkànen et al. demonstrated that impairment of CFR was seen even in young adult patients with type 1 diabetes of shorter duration without associated coronary artery disease (5) .
Intensive control of plasma glucose has been reported to effectively delay the onset and slow the progression of late diabetic microvascular complications in diabetic patients (6) . The effects of hypoglycemic therapy on coronary microcirculation have not yet been fully investigated. The primary objective of the present study was to investigate whether CFR impairment is also seen in well-controlled type 2 diabetic patients without ischemic heart disease, using noninvasive high resolution Doppler echocardiography.
On the other hand, hypertension is a quite common accompanying disorder in patients with diabetes, and also strongly affects the impairment of coronary flow reserve, even when the patients do not have left ventricular hypertrophy. To date, there have been very few reports investigating the relationship between diabetes mellitus without detectable macrovascular complications and CFR in distinction to the influence of hypertension. Therefore, the second objective of our study was to investigate the joint effect of hypertension and type 2 diabetes on impairment of CFR in patients without coronary artery disease.
Methods Subjects
Eighty-one patients with type 2 diabetes and/or essential hypertension who had attended our department for more than 3 years and 12 age-matched healthy control subjects (C group) were included in the present study. All examinations were conducted between September 1998 and March 1999. Twenty patients were excluded because they showed evidence of secondary hypertension, valvular, coronary or primary myocardial disease, arrhythmia or atrioventricular (AV) block, renal insufficiency, severe chronic obstructive pulmonary disease or bronchial asthma. Four patients whose Dopplerecho images of coronary flow were inadequate were also excluded. Thus, 57 patients were recruited and they were divided into three groups: patients with type 2 diabetes (DM group; n 24), patients with essential hypertension (HT group; n 15), and patients with both type 2 diabetes and essential hypertension (DM HT group; n 18). For 3 years before the start of the study, all patients had been receiving regular outpatient treatment once a month, their glycemia had been relatively well controlled (HbA1c 7.0%), and their blood pressure had been controlled by antihypertensive agents to less than 140/90 mmHg, as recommended by the Joint National Committee (JNC-VI) (7) . The mean duration of diabetes was 7.7 2.7 years and the mean duration of hypertension was 8.3 2.1 years (Tables 1-3 ). All control subjects were age-matched healthy volunteers, and none of them showed evidence of cardiovascular diseases, hypertension, diabetes or dyslipidemia. None of the controls were receiving any type of cardiovascular drug.
All subjects in the study had a low probability of having coronary artery disease based on the absence of cardiovascular symptoms, normal resting ECG and echocardiographic findings, and negative findings on maximal exercise-stress ECG. None of the patients showed evidence of LVH on Mmode echocardiography; left ventricular hypertrophy (LVH) was defined as a left ventricular mass ≥125 g/body surface area, a partition point supported by ample prognostic None of the diabetic patients had micro-or macro-albuminuria, malignant diabetic retinopathy (preproliferative or proliferative retinopathy (PDR)) or diabetic neuropathy, each of which has been associated with impaired vasodilator response of the coronary resistance vessels (9, 10) . The exclusion criterion for proteinuria was a urinary albumin index of 20, with the urinary albumin index being defined as urinary albumin adjusted for urinary creatinine (11) . Diabetic retinopathy was diagnosed by ophthalmoscopy within 1 month before CFR measurement, by experienced ophthalmologists. Patients who were diagnosed with simple diabetic retinopathy (SDR) were included in the study. Diabetic neuropathy was ruled out by standard neurological examinations by the attendant physicians. This study was approved by an institutional ethical committee, and all participants gave informed consent to the protocol. The procedures followed were in accordance with institutional guidelines.
CFR Measurement by Transthoracic Doppler Echocardiography
Transthoracic Doppler echocardiographic examinations were performed with an Acuson Sequoia digital ultrasound system with a frequency of 7.0 MHz (Acuson Sequoia, Mt. View, USA). The color gain was adjusted to provide optimal images. The acoustic window was around the midclavicular line in the fourth and fifth intercostal spaces in the left lateral decubitus position. The ultrasound beam was transmitted toward the heart to visualize coronary blood flow in the distal portion of the left anterior descending artery (LAD) by color Doppler flow mapping. First, the left ventricle was imaged in a long-axis cross-section; then the ultrasound beam was inclined laterally. Next, color Doppler flow mapping was used to locate the coronary blood flow in the distal LAD. Positioning a sample volume on the color signal in the distal LAD, Doppler spectral tracings of flow velocity were recorded by fast Fourier transformation analysis. The Doppler spectral tracing of the LAD flow showed a characteristic biphasic flow pattern with a larger diastolic component and a small systolic one. All studies were recorded on 0.5-inch s-VHS videotape for off-line analysis. We first recorded baseline spectral Doppler signals in the distal portion of the LAD. Adenosine was administered (140 µg/kg/min) for 3 min to record spectral Doppler signals during hyperemic conditions, following the published methods of Hozumi et al. (12, 13) . We did not correct the Doppler angle of coronary flow, because the coronary flow was almost parallel to the beam in all subjects. The position of the sample volume in LAD was always the same at the time of recording baseline and hyperemic coronary flow. All patients had continuous heart rate and ECG monitoring. Blood pressure was recorded at baseline, once every minute during adenosine infusion, and at recovery.
All examinations were performed under a fasting state in the morning. None of the control subjects were receiving any therapy at the time of the study. As for hypertensive subjects, antihypertensive drugs were discontinued at least 72 h before the study to remove acute effects of the drugs on hemodynamics (14) . Hypoglycemic medicine was passed over on the morning of the examination day, and resumed after the examination. All data for individual trials were analyzed by a single investigator who was blinded to the results of the other trials. Measurements were performed off-line by tracing the contour of the spectral Doppler signals using the computer incorporated in the ultrasound system. Peak diastolic velocity (PDV) was measured at baseline and at peak hyperemic conditions. An average of the measurements in three cardiac cycles was obtained. CFR was defined as the ratio of hyperemic to basal peak coronary flow velocity (12, 13) .
Conventional Echocardiographic and Carotid Ultrasonic Examinations
Transthoracic echocardiographic and carotid ultrasonic ex- (16) . Mitral inflow velocity was recorded by standard pulsedwave Doppler at the tips of the mitral valve. From the mitral inflow recordings, the ratio between early (E) and atrial (A) velocity (E/A) was obtained as an index of cardiac diastolic function.
The right common carotid artery was examined with the subject's head tilted slightly upward in the midline position. A region about 1.5 cm proximal to the carotid bifurcation was identified, and the intima-media thickness (IMT) of the far wall was evaluated as the distance between the luminal-intimal interface and the medial-adventitial interface. IMT measurements were obtained from five contiguous sites at 1-mm intervals, and the average of the five measurements was used for analysis. All measurements of IMT were made at a site free of any discrete plaques.
Statistical Analysis
All statistical analyses were conducted using StatView software (Abacus Concepts Inc., Berkeley, USA). All results are expressed as the means SD. Differences between groups were analyzed by ANOVA followed by Fisher's protected least significant difference test for continuous variables and by χ 2 test for categorical variables. Univariate analyses of the effects of each demographic and ultrasonic variable on CFR were performed with the linear regression model. Values of p 0.05 were interpreted as statistically significant.
Results

Patient Characteristics
The characteristics of the subjects are shown in Table 1 . There were no significant differences in age, BMI, lipid profile or smoking habit among the C, DM, HT and DM HT groups. Fasting blood glucose and HbA1c levels within 1 week of the examination day were significantly higher in subjects with diabetes than in those without diabetes, while they were similar in the DM and DM HT groups. Blood pressure on the CFR examination day was significantly higher in subjects with hypertension than in those without hypertension. Table 2 shows the comparison of clinical characteristics between the DM and DM HT groups. The average monthly HbA1c level over the past 3 years and duration of diabetes were similar in the two groups. No patients had experienced poor glycemic control (HbA1c level 8.0%) over the 3 years. The prevalence of simple diabetic retinopathy ( p 0.14) and the severity of albuminuria ( p 0.38) were not significantly different between the two groups. The types of administered hypoglycemic agents were almost identical between the two groups. Table 3 shows the comparison of clinical characteristics between the HT and DM HT groups. The average monthly blood pressure over the past 3 years indicates that the patients were appropriately controlled. There were no significant differences in blood pressure, duration of HT, or types of administered antihypertensive agents between the two 
Ultrasonic Parameters
The echocardiographic and carotid ultrasonographic variables in each group are shown in Table 4 . LVMI in the HT and DM HT groups was significantly higher than that in the DM group, and tended to be higher than that in the C group; however, no patient met the criteria of LVH, with LVH being defined as LVMI ≥ 125 g/m 2 (8) . RWT in the DM group was significantly higher than that in the C group. RWT in the HT and DM HT groups was significantly higher than that in the C and DM groups. The diastolic function of the HT and DM HT groups was also significantly worse than that in the C and DM groups. The IMT of the carotid artery was significantly higher in all three experimental groups than in the control group. And IMT in the DM HT group was significantly thicker than that in the DM and HT groups.
Side Effects and Hemodynamic Measurements during ATP Infusion
No serious side effects (AV block, bradycardia, chest pain, hypotension, or bronchospasm) occurred throughout the study. Six subjects had mild palpitation; however, their symptoms were so minor that all of them were able to complete the entire study. ATP administration induced a significant increase in heart rate and a slight decrease in systolic or diastolic blood pressure in some groups (Table 5 ). However, the hemodynamic changes were similar to those previously demonstrated in reports on CFR measurements using the same protocol (13).
Coronary Flow Reserve
There was no significant difference in peak diastolic coronary flow velocity at baseline among the four groups (C group: 20 3 cm/s; DM group: 20 4 cm/s; HT group: 21 5 cm/s; DM HT group: 22 4 cm/s). A significant increase in coronary flow was observed in all groups. However, peak diastolic coronary flow velocity during the hyperemic period was significantly lower in the HT group and tended to be lower in the DM HT group compared with the C and DM groups (C group: 60 14 cm/s; DM group: 57 14 cm/s; HT group: 47 10 cm/s; DM HT group: 51 11 cm/s). Consequently, the CFR in the DM group (2.92 0.46) was not reduced, while that in the HT (2.33 0.25) and DM HT groups (2.35 0.25) was significantly reduced compared with the C group (2.96 0.58) (Fig. 1) .
When we divided the subjects into two groups by the value of RWT, the subjects with RWT 0.45 (concentric remodeling group) showed significantly lower CFR than the subjects with RWT ≤ 0.45 (normal group) ( Table 6 ). However, when the analysis was limited to patients with hypertension, this tendency was not observed (Table 6 ). In all study 
Intra-Observer and Inter-Observer Variability in the Measurements of Coronary Flow Velocity
To verify the intra-and inter-observer variability in the measurement of coronary flow velocity, we performed the examination in 10 healthy control subjects without coronary artery diseases. The resulting intra-observer variability was 3.2% and the inter-observer variability was 3.1%.
Discussion
CFR has been recognized as one of the earliest markers of coronary arteriosclerosis and microangiopathy, and impairment of CFR in patients with diabetes has been generally demonstrated (1, 2, 5, 9) . In the present study, we performed noninvasive assessment of CFR using transthoracic Doppler echocardiography in well-controlled type 2 diabetes patients in order to estimate whether fair glycemic control and hypertension affects CFR in patients with diabetes.
Mechanism of Impairment of CFR in Patients with Diabetes, and Effect of Hypertension
At present, the exact mechanism of impairment of CFR in patients with diabetes is not completely understood. Histopathological studies in diabetic patients have shown abnormalities in coronary resistance vessels, including arteriolar thickening, perivascular accumulation of connective tissue, and capillary microaneurysms (17) . Microvascular morphological abnormalities have also been reported in diabetic animals (18) . Elevated global myocardial blood flow at rest due to tachycardia induced by autonomic dysfunction increases resting myocardial oxygen consumption and coronary artery blood flow (19) . Naturally, the presence of epicardial coronary arteriosclerosis is relevant to abnormal CFR (3, 4) . Recent clinical investigations have demonstrated that arterial wall atherosclerosis was found in about 94% of angiographically normal coronary arteries analyzed by intravascular ultrasound, and diabetes was independently related to the presence of atherosclerosis as determined by intravascular ultrasound (20) . Nevertheless, a reduction in CFR was not found in patients with diabetes under fair glycemic control in the present study. Akasaka et al. demonstrated that the CFR of diabetic patients with retinopathy was lower than that of diabetic patients without retinopathy, and that impairment of CFR was more prominent in patients with advanced (pre-proliferative) retinopathy than in those with early diabetic (background) retinopathy (9) . In our study, no patients had advanced retinopathy, and the CFR of patients with SDR in the DM group (2.64 0.19) was not significantly decreased, but tended to be lower than that in the C group (2.96 0.58). Our findings suggest that fair glycemic control delays the progression of coronary microangiopathy as well as other diabetic complications.
In patients with hypertension, several mechanisms have been demonstrated in regard to reduced CFR. LVH induced by high blood pressure has been associated with coronary vascular remodeling (21) and attenuated endothelial and non-endothelial coronary flow reserve (22) . In addition to structural remodeling of the coronary microvasculature and accumulation of fibrillar collagen in the myocardium (23), increased basal coronary flow at rest might be related to impairment of CFR (14, 24) . Palombo et al. have also reported that borderline hypertensive patients without LVH showed a significant reduction in CFR, and this reduction was related to increased minimum coronary resistance (25) . In the present study, patients with concentric left ventricular remodeling (RWT 0.45) showed significantly lower CFR than patients with normal left ventricular geometry (RWT ≤0.45), although they did not meet the criteria of LVH. However, the CFR of hypertensive patients with concentric remodeling did not decrease compared with that in hypertensive patients with normal left ventricular geometry. We assumed that the high normal limit of left ventricular structural changes was partly responsible for the functional abnormalities, based on the observed alterations of the intramyocardial arteries, increased perivascular fibrosis and increased myocardial fibrosis. However, the decrease in CFR was correlated not only to RWT and LVMI, but also to aging, blood pressure, diastolic function, and IMT. The mechanism of reduced CFR thus involves numerous factors and cannot be easily accounted for.
Our data also showed that hypertensive patients had slightly thicker IMT of the carotid arteries than did diabetic patients without hypertension. IMT of the common carotid artery is a sensitive parameter of general arteriosclerosis. De Simone et al. demonstrated that patients with mild ( 40%) coronary stenosis showed a moderate decrease (2.3 0.3) in CFR, comparable to that in our hypertensive patients (26) . Although the degree of general arteriosclerosis in our patients did not seem to be severe based on the carotid ultrasound results, we cannot rule out the possibility that increased coronary endothelial dysfunction due to very mild epicardial coronary arteriosclerosis might contribute to impaired CFR.
Regarding the possibility that chronic hyperglycemia or hyperinsulinemia per se may reduce CFR, the present result that well-controlled type 2 diabetes patients did not show a significant decrease of CFR suggested that diabetic coronary micro-and macroangiopathy could be prevented by strict glycemic control. It has been demonstrated that hypertension contributes to increased insulin resistance in patients with diabetes (27, 28) . Consequently, increased insulin resistance due to hypertension may be a leading cause of the progression of microvascular complications in patients with diabetes. Our data suggested that impairment of the CFR in the form of microvascular disturbance of the coronary circulation was also influenced or accompanied by hypertension in patients with diabetes. Insulin resistance should be assessed in patients with DM and HT in a future study.
Study Limitations
Transthoracic Doppler echocardiographic measurement of coronary flow does not measure the absolute volumetric flow in the LAD, but only the flow velocity. However, it has been reported that changes in coronary flow velocity induced by coronary vasodilation closely reflect changes in coronary blood flow (CFR measured by transthoracic Doppler echocardiography 0.95 CFR measured by coronary flow guide wire 0.21, r 0.94) (29) . There have been several reports comparing CFR measurment by this new technique with the other gold standard methods, Doppler flow wire (12) and PET (30) . CFR measured by transthoracic echocardiography showed a high correlation with CFR measured by the other established methods.
Although all our patients had absolutely no history of ischemic heart disease-related symptoms and no evidence of ischemic heart disease in clinical examinations that included ECG, echocardiography, and stress-ECG, coronary angiography was not performed for ethical reasons. Because the sensitivity and specificity in the diagnosis of epicardial coronary stenosis are relatively low, we cannot absolutely exclude the possibility that some of our patients had early-stage atherosclerosis of the coronary arteries.
Clinical Implications
Diabetes mellitus per se is one of the strongest risk factors for cardiovascular diseases; however, our study provides evidence that disturbance of the coronary microcirculatory function can be prevented by adequate glycemic control in diabetic patients without hypertension. This finding supports the results of the Diabetes Control and Complications Trial; i.e., intensive hypoglycemic therapy slows the progression of diabetic microvascular complications in the coronary arteries as well as other diabetic complications (6) . However, our data also demonstrated that accompanying hypertension in diabetic patients accelerated the disturbance of the coronary circulation, although these patients showed no evidence of retinopathy, nephropathy or macrovascular complications. The average blood pressure in the DM HT group over the past 3 years under medication was relatively good (135/86 mmHg). Our findings emphasize the importance of not only rigorous control of blood glucose, but also rigorous control of blood pressure in patients with diabetes and hypertension. Very recent clinical reports on blood pressure control in patients with diabetes mellitus by the American Diabetes Association recommended that an aggressive blood pressure-lowering target of 130/80 mmHg should be considered for delaying the onset of diabetic macro-and microvascular complications (31) . However, according to the recent report by Katayama et al., only one of ten Japanese hypertensive patients with diabetes received adequate antihypertensive treatment resulting in a blood pressure of less than 130/85 mmHg (32) . These authors also suggested that the ACE inhibitors or angiotensin II receptor blockers should be chosen as the first-line agents, based on clinical evidence (31) . Reduced CFR leads to poor prognosis of cardiac function (33) , and thus rigorous blood pressure-lowering therapy might be initiated before cardiac hypertrophy or diabetic complications become manifest. Further studies will be needed to acquire evidence of the efficacy of the rigorous anti-hypertensive therapy for preventing coronary microvascular complications in patients with hypertension or diabetes.
